I happy and proud to share our latest news with all of you – the regulatory approval of our Imaging Analytics Engine in Europe, Australia and New Zealand. Receiving CE approval marks another milestone for Zebra, as we continue to provide physicians and hospitals with a growing number of analytics tools to help them improve care.
The announcement, released earlier this week, detailed the algorithms that are now available in those regions. The algorithms are capable of identifying:
- Fatty liver
- Low bone density
- Vertebral Compression Fractures
- Coronary calcium levels
The Zebra analytics engine is completely automated, receiving imaging studies from PACS / VNA systems, and returning results to PACS, RIS, Dictation systems or EMR portals. To date, more than 500,000 studies have been analyzed by the engine, across North America, Latin America, China, India and Europe. Zebra’s engine is the most comprehensive deep learning imaging analytics engine currently in the market, and new capabilities are added nearly every month.
We continue to expand our engine with new capabilities – stay tuned for more exciting news in the coming months!